DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)

3.86 0.15 (4.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ZIOP $3.86 4.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.82
Previous Close $3.71
Daily Range $3.65 - $3.88
52-Week Range $2.31 - $5.58
Market Cap $396.5M
P/E Ratio -12.79
Dividend (Yield) $0.00 (0.0%)
Volume 697,189
Average Daily Volume 1,081,561
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drugs

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website: http://www.ziopharm.com/

News & Commentary

This Week in Biotech: PTC Therapeutics Surprises, Isis' Data Dazzles, and Provectus Sinks

Four positive clinical updates, a billion-dollar licensing deal, a surprising positive opinion for one company in the EU, and a rough NYSEArca debut for one biopharma are this week's top biotech stories.

ZIOPHARM Oncology (ZIOP) Is Strong On High Volume Today

Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast

ZIOPHARM Oncology (ZIOP) Jumps: Stock Moves Up 8.5% - Tale of the Tape

ZIOPHARM Oncology (ZIOP) in Focus: Stock Rises 10.4% - Tale of the Tape

Week In Review: PW Medtech Pays $130 Million For Fellow China Medical Device Company

Who Will Be Swimming Naked When The Tide Goes Out? (Part IV)

Ziopharm: Pipeline Expansion And Data Updates To Drive Near-Term Upside

Ziopharm Joins The CAR Crowd

ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And

ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And Clinical Program Update

Why Ziopharm Looks Worth Adding To Your Biotechnology Portfolio Pipeline

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $3.86 (4.04%)
Current stock: ZIOP
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
BIIB $303.55 (1.49%)
Current stock: BIIB